Oppenheimer & Co. Inc. Lowers Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Oppenheimer & Co. Inc. trimmed its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 17.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 18,407 shares of the company's stock after selling 3,833 shares during the period. Oppenheimer & Co. Inc.'s holdings in GE HealthCare Technologies were worth $1,439,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the company. Cherry Creek Investment Advisors Inc. boosted its stake in shares of GE HealthCare Technologies by 0.3% in the 4th quarter. Cherry Creek Investment Advisors Inc. now owns 37,351 shares of the company's stock valued at $2,920,000 after purchasing an additional 114 shares in the last quarter. Independence Bank of Kentucky grew its stake in shares of GE HealthCare Technologies by 6.0% during the fourth quarter. Independence Bank of Kentucky now owns 2,018 shares of the company's stock valued at $158,000 after buying an additional 114 shares during the last quarter. Tandem Capital Management Corp ADV increased its holdings in shares of GE HealthCare Technologies by 0.4% in the fourth quarter. Tandem Capital Management Corp ADV now owns 28,210 shares of the company's stock worth $2,205,000 after buying an additional 118 shares during the period. Arcus Capital Partners LLC lifted its stake in shares of GE HealthCare Technologies by 3.0% in the 4th quarter. Arcus Capital Partners LLC now owns 4,113 shares of the company's stock valued at $322,000 after acquiring an additional 119 shares during the last quarter. Finally, Custom Index Systems LLC boosted its holdings in GE HealthCare Technologies by 4.4% during the 4th quarter. Custom Index Systems LLC now owns 2,843 shares of the company's stock valued at $222,000 after acquiring an additional 120 shares during the period. Institutional investors own 82.06% of the company's stock.

Remove Ads

Wall Street Analyst Weigh In

GEHC has been the topic of several recent analyst reports. Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and raised their target price for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company upped their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the company an "overweight" rating in a research report on Friday, February 14th. Finally, Citigroup raised their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a "buy" rating in a research note on Thursday, February 13th. One analyst has rated the stock with a sell rating, three have given a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $97.67.

GE HealthCare Technologies Stock Up 1.4 %

Shares of GEHC stock traded up $1.17 during trading hours on Friday, hitting $86.58. 4,074,486 shares of the company's stock traded hands, compared to its average volume of 2,984,001. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.80. The stock has a market cap of $39.59 billion, a price-to-earnings ratio of 20.00, a PEG ratio of 3.19 and a beta of 1.13. The company has a quick ratio of 0.83, a current ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock's fifty day simple moving average is $86.63 and its two-hundred day simple moving average is $86.13.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, topping analysts' consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The company had revenue of $5.32 billion for the quarter, compared to analysts' expectations of $5.33 billion. On average, analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.